Showing results (241-250 of 390) with videos related to

Sort By:
Pageof 39
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility studyD Schrijvers, C Van Herpen, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2021
Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and/or metastatic salivary gland cancerWim van Boxtel, Maike J M Uijen, Stefanie D Krens, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 16, 2015
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the NetherlandsNaomi van der Linden, Jan Buter, Chris P Pescott, et al.
The American Journal of Cardiology|November 13, 2013
Comparison of prognosis in unrecognized versus recognized myocardial infarction in men versus women >55 years of age (from the Rotterdam Study)Abbas Dehghan, Maarten J G Leening, Abbas M Solouki, et al.
European Journal of Epidemiology|December 4, 2004
Serum carotenoids and vitamins in relation to markers of endothelial function and inflammationWendy M R van Herpen-Broekmans, Ineke A A Klöpping-Ketelaars, Michiel L Bots, et al.
Annals of Neurology|March 14, 2002
A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's diseaseSonia M Rosso, Esther van Herpen, Wout Deelen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2017
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trialChantal M L Driessen, Johannes M M Groenewoud, Jan Paul de Boer, et al.
BMC Cancer|March 3, 2022
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancerStefanie D Krens, Nielka P van Erp, Stefanie L Groenland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenibIngrid M E Desar, Alexander B Stillebroer, Egbert Oosterwijk, et al.
Targeted Oncology|December 23, 2014
Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscleAnna M J Thijs, Saloua El Messaoudi, Johanna C M Vos, et al.
Pageof 39